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Background: Racial disparities in breast cancer outcomes persist, with differen-
tial adverse outcomes in African American women. Although research has ex-
amined possible genetic differences, there has been little research on potentially 
modifiable characteristics such as health promoting behaviors. The purpose of 
this article is to describe the characteristics and to compare the differences by 
race in lifestyle factors and inflammatory biomarkers in African American and 
Caucasian women with breast cancer. 
Methods: This is a baseline descriptive analysis from an ongoing randomized 
controlled trial that includes 124 women diagnosed with early stage breast can-
cer prior to chemotherapy. Data sources included medical records, self-report 
questionnaires and a blood sample for measures of inflammation. The statistical 
analysis included descriptive statistics and ANOVA models to determine differ-
ences between the two groups.  
Results: Overall, both groups had low levels of health promoting behaviors. 
African Americans had a significantly higher body mass index. Caucasian wom-
en consumed more alcohol. Levels of C-reactive protein and MIP-1β were sig-
nificantly higher in African Americans.  
Conclusion: Potentially modifiable factors such as nutrition, physical activity 
and levels of inflammation warrant further attention.  
 
 
Article history: 
Received: Aug 28 2013 
Accepted: Dec 02 2013 
e-published: July 12 2014 
 
 
Keywords: 
Breast cancer, Biomarkers, 
Lifestyle, Disparities, C-
reactive protein  
 
*Corresponding Author: 
Debra E Lyon 
Tel: +1 352-273-6398;  
e-mail: delyon@ufl.edu  
 
 
 
 
 
 
 
 
Introduction 
 
The American Cancer Society projected 
that in the United States, there will be 
232,340 women diagnosed with breast can-
cerand that breast cancer will be the second 
largest cause for cancer deaths, following 
lung and bronchial cancer.
1  Breast cancer 
has been widely studied with respect to fac-
tors that contribute to its risk, incidence, 
progression, treatment response and recur-
rence. As of January 2012, the American 
Cancer Society (ACS) has estimated that 
there are more than 2.9 million women in 
the US who have a past history of invasive 
breast cancer.
1 The National Cancer Center 
database reports the 5-year survival rate for 
breast cancer as 88%, 81%, 74%, 67%, 41% 
and 49% for stages I, IIA, IIB, IIIA, IIIB 
and IIIC, respectively.
2 Some of the factors 
affecting breast cancer outcomes include 
socio-economic and environmental condi-
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tions, genetic predisposition and family his-
tory.
3  Over the years, significant advances 
have been made in early detection and 
screening of breast cancer patients. How-
ever, these steps have not resulted in uni-
form beneficial effects for all women. The 
National Cancer Institute defines "cancer 
health disparities" as adverse differences in 
cancer incidence (new cases), cancer preva-
lence (all existing cases), cancer death (mor-
tality), cancer survivorship, and burden of 
cancer or related health conditions that exist 
among specific population groups in the 
United States.
4 
African American women have the high-
est mortality rates and lower 5-year survival 
rates from breast cancer, in contrast to Cau-
casian women who have the highest inci-
dence and better survival rates. One of the 
reasons for this inequality could be that Af-
rican Americans are diagnosed in their later 
stages compared to Caucasians due to vari-
ous reasons.
5 African American women had 
more aggressive triple negative breast can-
cers than Caucasian women and this could 
probably be attributed to the heterogeneity 
of genetic marker expression of breast can-
cer in different races.
6 Studies show the ex-
istence of defective insulin secretion and a 
significant association between a specific 
polymorphism and type 2 diabetes in Afri-
can Americans when compared to Cauca-
sians. African Americans have higher serum 
insulin levels and insulin resistance.
7-9 These 
metabolic factors could play a role in cancer 
disparities.  However, there are potentially 
modifiable risks that warrant greater explo-
ration in breast cancer outcomes. 
 
Background and Literature Review 
In recent years, advanced and efficient 
screening practices and research have made 
possible early detection of breast cancer pa-
tients. Susceptibility to cancer is determined 
by various factors such as family history, ge-
netic predisposition, environmental factors 
and the presence of other illnesses or disor-
ders.
10-11  In addition, some modifiable risk 
factors for breast cancer such as body mass 
index (BMI), level of physical activity, nutri-
tion intake, alcohol consumption, smoking 
and health awareness have been identified. 
Biologically, inflammation is one of the 
hallmarks of cancer and plays a role in vari-
ous facets of tumor biology including initia-
tion, progression, angiogenesis and metasta-
sis.
12  Meta-analysis of studies analyzing the 
role of physical activity on breast cancer in-
cidence shows a 25% decrease in the inci-
dence when  comparing women with most 
physical activity to those with the least activ-
ity.
13 There is also some evidence that the 
synergistic effects of nutrition and physical 
activity may reduce the  reoccurrence of 
breast cancer.
14  Psychological well-being is 
also important in the survivorship of women 
with breast cancer. Almost 2% of women 
recently diagnosed with localized breast can-
cer reported symptoms of posttraumatic 
stress after the diagnosis.
11  Moreover, in-
creased spiritual well-being strongly corre-
lates with reduction in pain, anxiety and 
hopelessness and improvements in overall 
health and quality of life in cancer patients.
15-
16 From a biological perspective, a tumor mi-
croenvironment presents with inflammation 
and an increase in the levels of pro-in-
flammatory cytokines. Cell-based, pre-clini-
cal and clinical evidence show that inflam-
mation in the breast could play a role in the 
development of aggressive tumors.
17  Cyto-
kines are important molecules that are se-
creted as an immune response to inflamma-
tion, carcinogens and infections. Cytokines 
could be either pro-inflammatory (Interleu-
kin-1 [IL-1], Interleukin-6 [IL-6], Interleu-
kin-15 [IL-15], Interleukin-17 [IL-17], Inter-
leukin-23 [IL-23], Tumor Necrosis Factor- α 
[TNF-α]) or anti-inflammatory (Interleukin-
4 [IL-4], Interleukin-10 [IL-10], Interleukin-
13 [IL-13], Tumor Growth Factor [TGF]) 
and can be categorized into various sub-
families such as interleukins, interferons 
[IFN], colony stimulating factors, growth 
factors, TNFs and TGFs.
18  However, the 
relative proportions of pro-inflammatory 
and anti-inflammatory cytokines collectively 
dictate the overall inflammatory state of an 
individual. Increased concentrations of se-
rum IL-6 is associated with advanced stages Health Promotion Perspectives, Vol. 4, No. 1, 2014; P: 18-26 
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in various cancers such as prostate, breast 
and ovarian cancers.
19  IL-6 plays a role in 
promoting proliferation and survival of 
premalignant cells.
20  Similarly, IL-8 plays a 
role in the progression and reoccurrence of 
cancer in nasopharyngeal carcinoma and 
ovarian cancer respectively
21  IL-10 on the 
other hand acts as an inhibitory factor and 
suppresses the production of IL-1β, IL-6, 
IL8 and TNF-α.
22 C-reactive protein (CRP) 
is a protein synthesized in the liver and is 
found to increase in blood in response to 
inflammation. CRP is associated with tumor 
stage and the pathological features of colo-
rectal and breast cancers and is also a pre-
dictor of poor survival rates in patients with 
different malignancies.
23-27  In spite of ad-
vances in treatment, disparities in the risk 
and incidence of breast cancer in have been 
observed.
28 Concern associated with the ex-
isting trends has led the American Cancer 
Society to set elimination of cancer dispari-
ties as one of their challenge goals for 
2015.
29 
Research to examine  the interrelation-
ships of potentially modifiable biological 
factors such as levels of inflammation and 
potentially modifiable variables focusing on 
health promoting behaviors in different ra-
cial and ethnic groups is surprisingly lacking. 
Therefore, the current study sought to (a) 
describe the health promoting lifestyle beha-
viors, demographic characteristics, and in-
flammatory status of women with early stage 
breast cancer prior to chemotherapy and (b) 
to compare these variables in African Amer-
ican and Caucasian women. 
 
Materials and Methods 
 
Participants and Procedures  
This study was approved by the 
University’s Institutional Review Board after 
obtaining approval by the  institution’s 
Protocol Review and Monitoring System 
Committee. The sample for this study was 
from a randomized controlled trial to 
determine the effects of a portable, electrical 
device on the symptom experience of 
women receiving chemotherapy for early 
stage breast cancer. Participants were 
recruited from multiple sites affiliated with a 
National Cancer Institute Designated Cancer 
Center. Enrollment began in 2009 and was 
completed in 2013. Participants were greater 
than 18 years of age and were diagnosed 
with  early stage breast cancer.  All women 
had a performance score less than 2 
according to Eastern Cooperative Oncology 
Group criteria and were scheduled to receive 
neo-adjuvant or adjuvant chemotherapy. 
Potential participants were identified by their 
healthcare providers and were approached in 
the clinical setting or by telephone to 
ascertain interest in participation.  
Interested participants were assessed for 
eligibility using information provided by 
physicians and self-report. Individuals were 
consented and assessed prior to chemother-
apy initiation. Women were not enrolled in 
the study if they had dementia or active psy-
chosis, a history of a seizure disorder, had an 
implanted electrical device or had begun tak-
ing antidepressants or other psychotropic 
medications within 30 days of beginning 
chemotherapy  as this may have skewed 
questions regarding feelings of sadness as 
well as confounded inflammation results. 
 
Design 
This was an analysis of the baseline data 
from a randomized controlled trial. Partici-
pants were enrolled from a breast clinic in a 
university health science center with an 
NCI-designated Cancer Center. Participants 
were enrolled in the major clinic as well as 
three affiliate sites located across the State. 
Trained research personnel conducted par-
ticipant enrollment, consent and data collec-
tion. The demographic information for this 
analysis was collected from participants and 
medical records.  The behavioral data was 
self-report using a validated measure and 
was administered to participants by trained 
study personnel or completed by the partici-
pant after receiving instructions from trained 
study personnel. 
 
Measures 
Demographic and disease profile: In-
formation regarding patient demographic Lyon et al.: Health Promoting Life-Style Behaviors … 
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characteristics was ascertained using a stand-
ardized questionnaire.  
Health Promoting Lifestyle Profile: 
Information regarding patient lifestyle beha-
viors were  assessed using the Health Pro-
moting Lifestyle Profile II (HPLP-II). The 
HPLP-II is a 52-item scale, developed to 
measure health promoting behavior which 
was conceptualized as a multi-dimensional 
concept which includes initiation of actions 
and perceptions by an individual to maintain 
or enhance one’s own wellness.
30 Each item 
is rated on a four point scale from 1-4 and 
items are rated as “0” for never, “1” for 
sometimes, “2” often, and “3” for routinely. 
The HPLP scale has six domain including 
health responsibility, physical activity, nutri-
tion, spiritual growth, interpersonal relations 
and stress management. The total scores of 
the 6 subscales of health promoting behav-
iors were calculated by adding the 4-point 
Likert scale scores for all items within each 
subscale. The total score was calculated as 
the sum of all subscale scores. Lower scores 
indicate less health promoting behaviors. 
Sample items from the scale include items 
that ask respondents to indicate the fre-
quency with which they engage in health be-
haviors in positive ways.” The alpha coeffi-
cient of internal consistency for the total 
scale was 0.9; alpha coefficients for the sub-
scales ranged from 0.8 to 0.9. The 3-week 
test-retest stability coefficient for the total 
scale was 0.9.
30 
Inflammatory Biomarkers:  Inflamma-
tion was measured by serum cytokines (IL-
1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, 
IL-12, IL-13, IL-17, G-CSF, GM-CSF, IFN- 
γ, Monocyte Chemotactic Protein-1 [MCP-
1], Macrophage Inflammatory Protein-1β 
[MIP-1β], and TNF-α) and C-reactive pro-
tein (CRP). Blood was drawn by a trained 
healthcare professional in the clinical setting 
via venipuncture or from an implanted ac-
cess device. Blood was collected in an 8 ml 
vacutainer and transported for processing. 
Plasma was separated by centrifugation, and 
all specimens were aliquoted immediately, 
frozen, and stored in an  –80°C freezer. 
Plasma concentrations of the cytokines were 
measured with a 17-plex bioplex assay (Bio-
rad, Hercules, CA, USA). After incubation, 
contents of each microplate well were drawn 
into the Bio-Plex array reader (BioPlex Pro® 
(Bio-Rad; Hercules, CA, USA), and preci-
sion fluidics aligned the beads in a single file 
through a flow cell where two lasers excited 
the beads individually. High-speed digital 
signal processors and Bio-Plex Manager 
software (Bio-Rad) recorded the fluorescent 
signals simultaneously for each bead. Levels 
of CRP were determined with a high-sensi-
tivity enzyme-linked immunosorbent assay 
(DRG International Inc, NJ, USA). 
 
Data analysis 
Descriptive statistics were computed for 
demographic and disease characteristics and 
two-sample t-tests were calculated to deter-
mine the differences between the groups 
for continuous demographic and lifestyle 
variables and a likelihood ratio test for ca-
tegorical variables. Biological markers were 
log transformed in an attempt to satisfy the 
normality of the ANOVA models. The re-
placement values for biological markers less 
than the limit of detection were chosen to 
be 1/2 the distance between the smallest 
observed cytokine value and 0. The smallest 
observed cytokine value was determined 
from looking at multiple datasets from mul-
tiple  populations.  MANOVA was per-
formed to analyze differences in the cyto-
kine levels in African Americans and Cau-
casians.  Individual ANOVA models were 
run subsequent to the MANOVA for each 
cytokine and CRP to determine differences 
in race. All computations were completed 
using the JMP 10 statistical discovery soft-
ware from SAS. Level of significance was 
set at P = 0.05.  
 
Results 
 
Table 1 presents the demographics and 
disease characteristics data. Health characte-
ristics showed that  the mean weight and 
BMI of the participants were 178 pounds 
and 31 respectively and 61% were post-
menopausal.  Caucasian women had higher Health Promotion Perspectives, Vol. 4, No. 1, 2014; P: 18-26 
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educational attainment (87%) compared to 
73 % among the African American counter-
part (P<0.05). A marked difference was also 
observed in their marital status, especially in 
the subgroups of ‘never married’ and ‘cur-
rently married’. Twenty seven percent of the 
African American population had never 
been married versus 5% amongst Cauca-
sians. Fifty-one Caucasians were currently 
married compared to 19 African American 
women (P<0.002). Caucasians had a higher 
proportion of alcohol consumers (57%) 
(P=0.04), whereas African American women 
superseded them on the smoking parameter 
(82%). Forty-seven percent African Ameri-
can women were employed full time and 
27% were unemployed compared to 18% 
unemployment amongst Caucasians.   
 
 
Table 1: Demographics and Sample Characteristics 
 
 
 
Caucasian 
(n=79) 
African Amer-
ican 
(n=45) 
Total 
(n=124) 
P-value 
Age (mean ± SD)  52.7 ±10.13  51.1 ±8.39  52.2 ±9.47  0.3412* 
BMI (mean ± SD)  28.8 ±7.47  34.0 ±9.59  30.7 ±8.69  0.0012* 
Height (mean ± SD  64.4 ±2.67  63.5 ±3.09  64.0 ±2.90  0.0895* 
Weight (mean ± SD)  169.7±43.37  193.8 ±52.32  178.4 ±47.99  0.0105* 
Ethnicity (count (%)        0.6565† 
Not-Hispanic or Latino  74 (93.7%)  43 (95.6%)  117 (94.4%)   
Hispanic or Latino  5 (6.3%)  2 (4.4%)  7 (5.6%)   
Education (count (%)        0.0466†‡ 
Any education High School and less  10 (12.7%)  12 (27.3%) $  22 (17.9%) $$   
Any education beyond High School  69 (87.3%)  32 (72.7%)  101 (82.1%)   
Marital Status (count (%)        0.0018† 
Never Married  4 (5.1%)  12 (26.7%)  16 (12.9%)   
Currently Married  51 (64.6%)  19 (42.2%)  70 (56.5%)   
Previously Married  24 (30.4%)  14 (31.1%)  38 (30.6%)   
Employment (count (%)        0.7020†ǂ 
Employed Full-Time  41 (51.9%)  21 (46.7%)  62 (50.0%)   
Employed Part-time  15 (19.0%)  7 (15.6%)  22 (17.7%)   
Retired  9 (11.4%)  5 (11.1%)  14 (11.3%)   
Unemployed  14 (17.7%)  12 (26.7%)  26 (20.9%)   
Menopausal Status (count (%)        0.7648†# 
Pre-menopausal  32 (40.5%)  17 (37.7%)  49 (39.5%)   
Post-menopausal  47 (59.5%)  28 (62.3%)  75 (60.5%)   
Currently Smoking (count (%)        0.5063† 
Yes  18 (22.8%)  8 (17.8%)  26 (21.0%)   
No  61 (77.2%)  37 (82.2%)  98 (79.0%)   
Cigarettes per day (mean ± SD)  2.7 ±6.04  1.6 ±4.23  2.3 ±5.46  0.2264* 
ETOH Intake        0.0392† 
Yes  45 (57.0%)  17 (37.8%)  62 (50.0%)   
No  34 (43.0%)  28 (62.2%)  62 (50.0%)   
Drinks per week (mean ± SD)  3.2 ±8.09  1.5 ±4.16  2.6 ±6.90  0.1096* 
SD: Standard Deviation/* Using a two-sample, t-test./† Using the likelihood ratio test for the r x 2 contingency ta-
ble./‡ Categories for “Didn’t finish High School” and “High School Diploma” were collapsed as ‘Any education 
High School and below’ to satisfy test assumptions./
ǂ Categories for “Unemployed”, “Disabled” and “Student” were 
collapsed as ‘Unemployed’ to satisfy test assumptions./# Categories for “Pre-menopausal” and Peri-menopausal” 
were collapsed as ‘Pre-menopausal’ to satisfy test assumptions./$ N= 44 $$ N=123 Lyon et al.: Health Promoting Life-Style Behaviors … 
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Table 2 summarizes responses to the subs-
cales for health responsibility, physical activi-
ty, nutrition, spiritual growth, interpersonal 
relations and stress management. The overall 
lifestyle score had little variability among 
participants. The participants had high levels 
of Lifestyle Interpersonal Relations score 
(sub-scale mean=31), followed by spiritual 
growth (sub-scale mean=29) and lower le-
vels of physical activity (sub-scale mean=17). 
The overall lifestyle score as well as the 
mean score for different scales did not reach 
significance between races except for nutri-
tion with  African Americans having lower 
scores on the subscalewhen compared to 
Caucasian women (P = 0.007). 
Levels of CRP and Cytokines: Blood was 
drawn from 118 participants and the levels 
of cytokines and CRP was analyzed using a 
17-plex bioplex assay. The pro-inflammatory 
and anti-inflammatory cytokines analyzed 
comprised of CRP, Interleukins, Granulo-
cyte-CSF (G-CSF), Granulocyte Macro-
phage-  CSF (GM-CSF),  IFN-γ, MCP-1, 
MIP-1β and TNF-α. Table3 shows the val-
ues for each of these cytokines in pico-
grams/ml (median (minimum/maxi-mum) 
and also states the percentage of samples 
that had values below the level of detection. 
IL-2, IL-10, IL-17 and GM-CSF had more 
than 50% of the samples that had unde-
tected values. Biomarkers were compared in 
75 Caucasians and 43 African Americans. 
Levels of CRP were generally elevated, with 
a maximum of 35.31 pg/ml and a median of 
3.76pg/ml. The African American group 
showed higher median for all the cytokines 
measured and CRP when compared to the 
Caucasian participants, except for IL-7 and 
MCP-1. It is of note that two anti-
inflammatory cytokines IL-4 and IL-13 also 
showed higher median values (0.58 and 0.46 
pg/ml respectively) in African Americans 
than Caucasians (Table 3).  
Figure 1 shows the cytokine means and 
standard errors (in  log picograms per ml) 
that illustrate the differences between the 
Caucasian and African American women 
with early stage breast cancer. P-values from 
the ANOVA of each cytokine and CRP are 
listed in Table 3. They indicate that the le-
vels of CRP (P= 0.02) and MIP-1β (P= 0.01) 
were significantly higher and MCP-1  (P= 
0.06) and IFN-γ (P = 0.09) were marginally 
significant in African Americans when com-
pared to Caucasians. 
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Fig. 1: Differences in Levels of Cytokines in African American and Caucasian women  
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Table 2: Subscales for Lifestyle Behavior 
 
Lifestyle Domains 
Caucasians 
(n=79) 
African Americans 
(n=45)  All (n=124)       
 
Mean ± SD  Mean ± SD  Mean ± SD  t  df  P 
Total Lifestyle score  148.50 ± 19.73  148.64± 21.33  148.55 ± 20.27  -0.04  122  0.971 
Health Responsibility  23.92 ± 5.33  25.27± 4.76  24.41 ± 5.23  -1.45  122  0.149 
Physical Activity  17.42 ± 5.42  16.69± 5.37  17.15 ± 5.46  0.73  122  0.469 
Nutrition  26.06 ± 4.80  23.98± 4.29  25.31 ± 4.68  2.48  122     0.014 * 
Spiritual Growth  28.87 ± 4.18  29.62± 4.90  29.15 ± 4.45  -0.86  122  0.389 
Interpersonal Relations  30.73 ± 3.91  30.29± 4.02  30.57 ± 3.90  0.59  122  0.555 
Stress Management  21.49 ± 4.18  22.8± 4.56  21.97 ± 4.34  -1.58  122  0.116 
P-Value based on independent t-test considering equal variancesfor comparing Caucasians and African Americans/*: Significant difference / 
SD: Standard Deviation 
 
Table 3: Levels of CRP and Cytokines 
 
 
Caucasians (n=75)  African Americans (n=43)  All (n=118)  P-value 
 
Median (Min/Max)  % BLD  Median (Min/Max)  % BLD  Median (Min/Max)  % BLD 
CRP  2.81(0.04/24.90)  0  6.36(0.06/35.31)  0  3.76(0.04/35.31)  0  0.02  
IL-1β  0.15 (0.01/2241.53)  29  0.39 (0.01/73.35)  28  0.20 (0.01/2241.53)  29  0.30 
 IL-2  0.01 (0.01/2821.84)  72  0.01 (0.01/27.88)  79  0.01 (0.01/2821.84)  75  0.25 
 IL-4  0.22 (0.01/1400.00)  23  0.58 (0.01/11.23)  19  0.33 (0.01/1400.00)  21  0.32  
 IL-5  0.33 (0.01/1034.36)  25  0.36 (0.01/2.87)  26  0.35 (0.01/1034.36)  25  0.61 
 IL-6  2.07 (0.01/3132.48)  27  3.69 (0.01/20.52)  19  2.60 (0.01/3132.48)  24  0.14 
 IL-7  4.73 (0.01/3072.16)  1  4.15 (0.14/23.83)  2  4.54 (0.01/3072.16)  1  0.32 
 IL-8  5.15 (1.40/104.10)  0  7.03 (1.63/446.50)  0  5.83 (1.40/446.50)  0  0.33 
 IL-10  0.01 (0.01/3867.50)  67  0.01 (0.01/197.38)  70  0.01 (0.01/3867.50)  68  0.77 
 IL-12  1.73 (0.01/14071.40)  27  3.39 (0.01/122.89)  23  1.95 (0.01/14071.40)  25  0.60 
 IL-13  0.16 (0.01/2490.48)  47  0.46 (0.01/88.71)  37  0.21 (0.01/2490.48)  43  0.70 
 IL-17  0.01 (0.01/771.19)  68  0.01 (0.01/98.43)  53  0.01 (0.01/771.19)  63  0.19 
 G-CSF  8.01 (0.10/3155.28)  8  10.83 (0.10/33.83)  9  9.30 (0.10/3155.28)  8  0.93 
 GM-CSF  0.01 (0.01/8562.68)  60  0.01 (0.01/180.51)  60  0.01 (0.01/8562.68)  60  0.86 
IFN-γ  11.93 (0.10/29359.56)  31  23.70 (0.10/524.14)  14  17.88 (0.10/29359.56)  25  0.09 
 MCP-1  31.04 (5.35/2715.62)  0  28.15 (5.42/106.03)  0  30.39 (5.35/2715.62)  0  0.06 
 MIP-1β  74.14 (28.24/165.87)  0  87.04 (28.24/335.37)  0  76.21 (28.24/335.37)  0  0.01 
 TNF-α  2.47 (0.01/24874.18)  19  3.35 (0.01/22.36)  16  2.83 (0.01/24874.18)  18  0.92 
P-Value based on individual ANOVAs between Caucasians and African Americans/ BLD: Below levels of detectionLyon et al.: Health Promoting Life-Style Behaviors … 
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Discussion 
 
The purpose of the current study was to 
understand the health promoting lifestyle 
behaviors, demographic information, and 
inflammatory status of women with early 
stage breast cancer prior to chemotherapy 
and further compare these variables in Afri-
can American and Caucasian women. BMI 
was elevated in the majority of the sample, 
irrespective of race (Table 1) and levels of 
physical activity were low (Table  2). Both 
obesity and physical activity are interrelated 
and is an avenue that should be addressed to 
enhance outcomes in women with breast 
cancer.
31-32 
In this study, African American women 
had lower scores on the nutritional subscale 
and this could have contributed toan adverse 
inflammatory state in the balance between 
the pro-inflammatory and the anti-
inflammatory cytokines.
33  Inflammation 
could also contribute to insulin resistance 
and disruptions in leptin levels. Women of 
all races benefitted from physical activity; 
however, a particularly strong effect on 
breast cancer risk has been observed in non-
Caucasian women.
13 It has also been specu-
lated that this association may be attributed 
to various biological pathways such as adi-
posity, insulin resistance and chronic in-
flammation.
34  Altogether, this calls for a 
careful assessment of nutritional status and 
body composition of women in general, and 
particularly, in women with early stage breast 
cancer. In this study, African Americans had 
a higher median level for multiple cytokines 
when compared to the Caucasian partici-
pants, except for IL-7 and MCP-1 (Table 3). 
We also observed significantly higher levels 
of CRP and MIP-1β  in  African  American 
women than in Caucasian women with 
breast cancer. CRP is an important bi-
omarker of inflammation that may have 
prognostic value in breast cancer.
35 MIP-1β 
guides mononuclear phagocytes to form ma-
ture macrophages that serve as the main 
source of growth factors and cytokines and 
also stimulates production of proteolytic en-
zymes such as matrix metalloproteinases 
(MMPs).
 12 
Conclusion 
   
This study highlights potentially modifia-
ble health promoting behaviors that, if ad-
dressed, could lead to more optimal self-
management strategies for women with 
breast cancer. This study also identified sev-
eral differences in inflammatory biomarkers 
hat warrant further research. With the pre-
diction that the number of breast cancer 
survivors willreachthe level of 3.4 million 
individuals by the year 2015, more research 
is needed to improve the quality of life of 
this growing group of individuals.
36 Address-
ing potentially modifiable health promoting 
behaviors early in treatment may set a better 
stage for optimal long-term outcomes of 
survivors and may decrease some of the dis-
parities in breast cancer outcomes.  
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